Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Extension in Epilepsy
NCT02427607Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2015
- Primary completion
- Sep 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perampanel in epilepsy, sponsored by Eisai Co., Ltd.. Started May 2015; status: completed.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02427607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427607.